Attorney for Pharmaceutical Sales Fraud

Pharmaceutical sales fraud is a serious and complex area of law that affects sales representatives, healthcare providers, pharmaceutical companies, whistleblowers, and patients throughout New York City. Whether you are facing allegations of misconduct, have uncovered fraudulent practices within your organization, or are a company responding to a government investigation, the stakes are extraordinarily high. Substantial financial penalties, professional licensing consequences, and even criminal liability can result from these matters.

Our firm represents clients across all five boroughs in pharmaceutical sales fraud cases. We bring a thorough understanding of both New York State law and the regulatory framework that governs the pharmaceutical industry. This page explains what pharmaceutical sales fraud involves, the legal exposure you may face, and how an experienced attorney can protect your rights and interests.

What Is Pharmaceutical Sales Fraud?

Pharmaceutical sales fraud encompasses a wide range of deceptive practices related to the marketing, promotion, and sale of prescription drugs and medical products. These cases often arise from aggressive sales tactics that cross legal and ethical boundaries. Common forms of pharmaceutical sales fraud include:

• Off-label marketing: Promoting a drug for uses not approved by regulatory authorities.
• Kickback schemes: Offering or receiving improper payments, gifts, or incentives to influence prescribing decisions.
• Misrepresentation of drug efficacy or safety: Making false or misleading claims about a product's benefits or risks.
• Fraudulent billing: Submitting false claims to government healthcare programs or private insurers.
• Sample diversion: Improperly distributing or reselling drug samples intended to be free.
• Concealment of adverse events: Failing to report known safety concerns associated with a medication.

These practices can lead to investigations under New York law, including actions brought under the New York False Claims Act and prosecutions for fraud, larceny, and related offenses involving the state's healthcare and insurance systems.

New York Law Governing Pharmaceutical Fraud

New York maintains robust statutes designed to combat fraud against state programs and consumers. The New York False Claims Act (State Finance Law Article 13) allows the state and private individuals to pursue claims against those who knowingly submit false claims to government-funded programs, including Medicaid. New York is one of the jurisdictions with a particularly strong false claims statute, which extends to tax fraud in certain circumstances and permits substantial recoveries.

Pharmaceutical sales fraud may also implicate provisions of the New York Penal Law, including charges related to scheme to defraud, grand larceny, falsifying business records, and insurance fraud. When fraud involves the state Medicaid program, the New York Office of the Medicaid Inspector General and the Attorney General's Medicaid Fraud Control Unit may become involved in investigations and enforcement actions.

In addition, New York General Business Law contains consumer protection provisions that can apply to deceptive marketing of pharmaceutical products. Healthcare professionals involved in fraudulent schemes may face disciplinary proceedings before state licensing authorities, jeopardizing their ability to practice.

Whistleblower Protections Under New York Law

Many pharmaceutical sales fraud cases begin when an employee or insider comes forward to report wrongdoing. New York provides meaningful protections and incentives for whistleblowers. Under the New York False Claims Act, a private individual—known as a relator—may file a qui tam action on behalf of the state. If the action is successful, the whistleblower may be entitled to a percentage of the recovered funds.

New York law also protects employees from retaliation. Labor Law Section 740, the state's whistleblower statute, prohibits employers from taking adverse action against employees who disclose or threaten to disclose illegal activities that pose a danger to public health or safety, or that violate the law. Recent amendments have broadened these protections, making it easier for employees to assert claims when they reasonably believe a violation has occurred.

If you have witnessed fraudulent practices in the pharmaceutical industry, consulting with an attorney before taking action is critical. Proper documentation, timing, and procedural compliance can significantly affect the outcome of a whistleblower claim and your eligibility for protection and reward.

Defending Against Pharmaceutical Sales Fraud Allegations

Being accused of pharmaceutical sales fraud does not mean you are guilty. Sales representatives and companies often face allegations based on aggressive interpretations of marketing conduct, ambiguous regulatory guidance, or the actions of others within an organization. A strong defense requires careful analysis of the evidence and applicable law.

Effective defense strategies may include:

• Demonstrating a lack of fraudulent intent or knowledge of wrongdoing
• Establishing that the conduct fell within lawful and approved marketing practices
• Challenging the sufficiency and reliability of the government's evidence
• Identifying procedural errors in the investigation
• Negotiating favorable resolutions where appropriate

Because these cases frequently involve parallel civil, criminal, and administrative proceedings, coordinated and strategic representation is essential. Statements made in one forum can have serious consequences in another, making early legal involvement vital.

Who We Represent

Our firm provides representation to a range of clients involved in pharmaceutical sales fraud matters throughout New York City, including:

• Pharmaceutical sales representatives facing allegations of improper conduct
• Whistleblowers and relators seeking to report fraud and pursue qui tam claims
• Healthcare providers accused of participating in kickback or fraud schemes
• Pharmaceutical companies responding to government investigations
• Employees who have suffered retaliation for reporting wrongdoing

Potential Consequences of Pharmaceutical Fraud

The penalties associated with pharmaceutical sales fraud can be severe. The following table summarizes some of the consequences that may arise from these matters under New York law:

Why Choose Our New York Pharmaceutical Fraud Attorneys

Pharmaceutical sales fraud cases demand attorneys who understand both the legal framework and the realities of the pharmaceutical industry. Our team offers:

• In-depth knowledge of New York law governing false claims, healthcare fraud, and whistleblower protections
• Experience handling complex investigations involving multiple regulatory bodies
• A client-centered approach focused on protecting your rights, reputation, and future
• Strategic counsel tailored to the unique facts of your situation

We recognize that every case is different, and we work closely with each client to develop a tailored strategy that addresses their specific goals and concerns.

Take Action to Protect Your Rights

If you are involved in a pharmaceutical sales fraud matter in New York City—whether as someone facing allegations, a whistleblower considering coming forward, or an employee who has experienced retaliation—time is often a critical factor. Investigations can move quickly, deadlines for filing claims apply, and early decisions can shape the entire course of a case.

Do not navigate these high-stakes matters alone. Contact our office today to schedule a confidential consultation. We will listen to your situation, explain your options under New York law, and help you take the next steps to protect your interests and your future.

You can contact us by phone at 212-233-1233 or by email at [email protected].